Home/Filings/4/0001144204-16-079694
4//SEC Filing

ENDOCYTE INC 4

Accession 0001144204-16-079694

CIK 0001235007operating

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 8:51 PM ET

Size

8.7 KB

Accession

0001144204-16-079694

Insider Transaction Report

Form 4
Period: 2016-02-04
Parker Katherine
VP of Human Resources
Transactions
  • Award

    Stock Option (right to buy)

    2016-02-04+37,50037,500 total
    Exercise: $3.18Exp: 2026-02-04Common Stock (37,500 underlying)
  • Award

    Common Stock

    2016-02-04+6,25017,608 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,200
  • Common Stock

    (indirect: By Trust)
    1,200
Footnotes (3)
  • [F1]Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on February 4, 2017, in the form of one share of common stock for each restricted stock unit.
  • [F2]Includes 391 and 587 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2015 and December 15, 2015, respectively.
  • [F3]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 4, 2017.

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001235007

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 8:51 PM ET
Size
8.7 KB